Markets
U.S. close in 6 hrs, 6 mins
BUSINESS NEWS
- Market News
- Earnings
- Recalls
- Recession Watch
- Tech News
- Madoff Scandal
- BloggingStocks
- Luxist
- Money Videos
INVESTING
- Stock Quotes
- Stock Charts
- Stock Ticker
- Currencies
- Portfolio
- Stock Screener
- Broker Center
- Mutual Fund Center
- ETF Center
- Money
- 24/7 Wall St.
- Financial Glossary
PERSONAL FINANCE AT WALLETPOP
- Bargains
- Banking
- Budget
- Calculators
- College Finance
- Community
- Credit
- Deals
- Debt
- Economizer
- Food
- Home
- Fraud
- Insurance
- Interest Rates
- Loans
- Mortgages
- Real Estate
- Recalls
- Recession
- Retirement
- Saving
- Simplification
- Specials
- Taxes
SMALL BUSINESS
AGA Medical to Host Earnings Conference Call on Tuesday, February 16, 2010
Business Wire
AGA Medical Holdings, Inc. (AGA Medical) (Nasdaq: AGAM) will hold a live
webcast to discuss its fourth quarter and full year 2009 operating
results on Tuesday, Feb. 16, 2010 at 8 a.m. ET (7 a.m. CT), hosted by
John Barr, President and Chief Executive Officer, and Brigid Makes,
Chief Financial Officer. The Company will issue an earnings release at
approximately 7 a.m. ET (6 a.m. CT) also on Tuesday, Feb. 16, 2010.
To access the webcast, please go to the investor relations section of
the AGA Medical Web site (
www.amplatzer.com)
and click on the webcast icon under the “IR Calendar” section. The
webcast will be available for replay approximately one hour after the
presentation is complete.
To participate in the conference call, please dial (888) 713-4211 and
enter 68231599. Please dial in at least 10 minutes prior to the call. If
you do not have access to the Internet and want to listen to an audio
replay of the conference call, please dial (888) 286-8010 and enter
access number 55139073.
About AGA Medical
AGA Medical, based in Plymouth, Minnesota, is a leading innovator and
manufacturer of medical devices for the treatment of structural heart
defects and vascular abnormalities. AGA Medical’s
AMPLATZER
occlusion devices offer minimally invasive, transcatheter treatments
that have been clinically shown to be safe and highly effective in
defect closure. AGA Medical is the only manufacturer with occlusion
devices approved to close seven different structural heart defects, with
leading market positions for each of its devices. More than 1,500
articles supporting the benefits of AMPLATZER products have been
published in medical literature. AGA Medical markets its AMPLATZER
products in 112 countries worldwide to interventional cardiologists,
electrophysiologists, interventional radiologists and vascular surgeons.
More information about the company and its products can be found at
http://www.amplatzer.com.
Copyright Business Wire 2010
2010-02-08 18:00:00
COMMENTS ( 0 )